Icosagen Therapeutics

Booth 3145
Tartu, Estonia
Icosagen, a leading CRDMO for the biopharmaceutical, biotechnology, and diagnostic industries, was founded in 1999. In 2022, we worked with 100+ companies, producing 3000+ proteins. Our seamless services include early clinical candidate development and stable CHO cell line development for 50L to 1000L GMP production runs. Clients trust us for custom-tailored solutions in every stage of drug development, from complicated protein discovery to recombinant production.